Mutations in the MYBPC3 gene are the leading genetic cause of Hypertrophic Cardiomyopathy (HCM) reducing levels of functional MYBP-c protein.
DIFFERENCES IN PATIENT CHARACTERISTICS AND BURDEN OF DISEASE IN ADULTS WITH MYBPC3-ASSOCIATED HCM / Wang, Whedy; Varfaj, Bardha; Robertson, Laura; Harrison, William; Haroldson, Jeff; Tingley, Whittemore; Lakdawala, Neal K.; Owens, Anjali Tiku; Saberi, Sara; Lin, Kimberly Y.; Stendahl, John; Parikh, Victoria; Ingles, Jodie; Ashley, Euan A.; Ware, James; Michels, Michelle; Lampert, Rachel J.; Abrams, Dominic J.; Rossano, Joseph William; Russell, Mark W.; Ryan, Thomas D.; Olivotto, Iacopo; Day, Sharlene M.; Ho, Carolyn; Helms, Adam. - In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. - ISSN 0735-1097. - ELETTRONICO. - 85:(2025), pp. 0-0. [10.1016/s0735-1097(25)01997-7]
DIFFERENCES IN PATIENT CHARACTERISTICS AND BURDEN OF DISEASE IN ADULTS WITH MYBPC3-ASSOCIATED HCM
Olivotto, Iacopo
;
2025
Abstract
Mutations in the MYBPC3 gene are the leading genetic cause of Hypertrophic Cardiomyopathy (HCM) reducing levels of functional MYBP-c protein.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



